L'angioplastie coronaire chez le patient age. [Coronary angioplasty in elderly patients]

Détails

ID Serval
serval:BIB_1152C51CF17A
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
L'angioplastie coronaire chez le patient age. [Coronary angioplasty in elderly patients]
Périodique
Schweizerische Rundschau fur Medizin Praxis
Auteur(s)
Eeckhout  E., Stauffer  J. C., Vogt  P., Kappenberger  L., Goy  J. J.
ISSN
1013-2058 (Print)
Statut éditorial
Publié
Date de publication
02/1996
Volume
85
Numéro
6
Pages
168-71
Notes
English Abstract
Journal Article
Review --- Old month value: Feb 6
Résumé
Percutaneous transluminal coronary angioplasty (PTCA) is a widely accepted treatment of symptomatic coronary heart disease providing prompt and prolonged clinical, improvement in most patients. We have examined the value of this therapy in a group of 91 patients in their eighth decade treated by 133 consecutive angioplasties. Most patients had refractory or instable angor in spite of optimal pharmacotherapy. Multivessel disease was present in 67% and maintained left-ventricular function in 92% of the patients. The angiographic success rate of PTCA was 84%; technical failures occurred in 12% and adverse events in 14%. Two patients died. The rate of symptomatic restenosis was 24%. Survival and patients free of myocardial events were at 89% and 60%, respectively, estimated by Kaplan-Meier analysis. PTCA is an efficient and acceptable treatment for the elderly patient with severe and drug-resistant angina. Two years after PTCA the majority of patients was asymptomatic.
Mots-clé
Aged Aged, 80 and over *Angioplasty, Transluminal, Percutaneous Coronary/mortality Coronary Disease/*therapy Female Humans Male Recurrence
Pubmed
Création de la notice
28/01/2008 9:52
Dernière modification de la notice
20/08/2019 12:38
Données d'usage